Markers that differentiate early from late IBD.
The worldwide emergence of autoimmune and chronic disorders has become a substantial burden to our current healthcare system. The evidence that IBD can manifest at either an early or late stage of evolution poses some intriguing questions: are there any markers that differentiate early from late IBD? In this article we explore the current data to better understand if any of these genetic, serologic, clinical course and/or microbiota markers do indeed serve to differentiate early from late IBD.
Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, Emory University School of Medicine and Children's Healthcare of Atlanta, Atlanta, GA 30322, USA.
Clifton
C
Huang
Subra
S
Kugathasan
D015415:Biomarkers / Q000097:blood*; D018450:Disease Progression; D005819:Genetic Markers; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000097:blood* / Q000175:diagnosis* / Q000382:microbiology; D054892:Metagenome
D015415:Biomarkers; D005819:Genetic Markers